Meenal Chalukya

发表

Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.

K. Devriendt, G. Mortier, E. Jabs, 2001, Human molecular genetics.

PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.

C. Sawyers, G. Martinelli, R. Paquette, 2007 .

Developmental or degenerative – NR2E3 gene mutations in two patients with enhanced S cone syndrome

M. Marmor, N. Udar, K. Small, 2011, Molecular vision.

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

V. Velculescu, Siân Jones, L. Hartmann, 2011, Clinical Cancer Research.

A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy

J. Haines, M. Pericak-Vance, D. Weeks, 2002, Ophthalmic genetics.

Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients

N. Udar, K. Small, V. Yellore, 2003, Human mutation.

Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.

C. Sawyers, R. Paquette, N. Shah, 2010, Leukemia research.

Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer

Nitin Udar, Boris Winterhoff, V. Velculescu, 2013, Molecular Cancer Therapeutics.

Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors.

Gouri Nanjangud, David Elashoff, John Nicoll, 2011, Cancer genetics.

Identification of GUCY2D gene mutations in CORD5 families and evidence of incomplete penetrance

Larry Donoso, L. Donoso, Meenal Chalukya, 2003, Human mutation.

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

C. Sawyers, L. Gondek, R. Paquette, 2008 .